Camp4 Therapeutics Corp cotiza a 3.43 USD y tiene una capitalización bursátil de $215M. En los últimos 12 meses ha facturado $4M con un margen de flujo de caja libre del -852.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for t…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.21 | $-0.23 | $-0.54 | $-0.62 |
| Estimado | $-0.21 | $-0.29 | $-0.48 | $-0.67 |
| Sorpresa | +0.0% | +20.7% | -12.5% | +7.5% |
| Métrica | CAMP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -1502.4% | -38.6% | -1463.8% |
| Net Margin | -2298.5% | -33.6% | -2265.0% |
| FCF Margin | -852.8% | -13.9% | -839.0% |
| ROE | -168.6% | -40.4% | -128.2% |
| ROA | -68.3% | -32.0% | -36.2% |
| Current Ratio | 7.35 | 2.84 | +4.51 |
| Debt / Equity | — | 0.28 | — |